ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Charmacy Pharmaceutical Co., Ltd. ?
1
High Debt company with Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 1.16% and Operating profit at 8.41% over the last 5 years
- The company is Net-Debt Free
2
Flat results in Dec 25
- ROCE(HY) Lowest at 7.47%
- DEBTORS TURNOVER RATIO(HY) Lowest at 3.35 times
- DEBT-EQUITY RATIO (HY) Highest at 237.99 %
3
With ROE of 7.31%, it has a Very Expensive valuation with a 1.15 Price to Book Value
- Over the past year, while the stock has generated a return of 3.55%, its profits have fallen by -13.1%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Charmacy Pharmaceutical Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Charmacy Pharmaceutical Co., Ltd.
3.55%
-0.34
45.03%
Hang Seng Hong Kong
0.26%
0.01
20.12%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
1.16%
EBIT Growth (5y)
8.41%
EBIT to Interest (avg)
2.06
Debt to EBITDA (avg)
7.90
Net Debt to Equity (avg)
2.02
Sales to Capital Employed (avg)
1.93
Tax Ratio
28.00%
Dividend Payout Ratio
73.93%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.32%
ROE (avg)
8.99%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
1.15
EV to EBIT
17.10
EV to EBITDA
13.39
EV to Capital Employed
1.04
EV to Sales
0.50
PEG Ratio
NA
Dividend Yield
4.24%
ROCE (Latest)
6.11%
ROE (Latest)
7.31%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
OPERATING CASH FLOW(Y)
Highest at HKD 412.24 MM
INTEREST COVERAGE RATIO(Q)
Highest at 280.25
RAW MATERIAL COST(Y)
Fallen by -16.95% (YoY
CASH AND EQV(HY)
Highest at HKD 839.37 MM
-7What is not working for the Company
ROCE(HY)
Lowest at 7.47%
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.35 times
DEBT-EQUITY RATIO
(HY)
Highest at 237.99 %
PRE-TAX PROFIT(Q)
Lowest at HKD 34.68 MM
Here's what is working for Charmacy Pharmaceutical Co., Ltd.
Interest Coverage Ratio
Highest at 280.25
in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Operating Cash Flow
Highest at HKD 412.24 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (HKD MM)
Cash and Eqv
Highest at HKD 839.37 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -16.95% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Charmacy Pharmaceutical Co., Ltd.
Debtors Turnover Ratio
Lowest at 3.35 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Pre-Tax Profit
Lowest at HKD 34.68 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (HKD MM)
Debt-Equity Ratio
Highest at 237.99 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
